IDPC welcomes the Board's increasing focus on human rights issues and cannabis regulation, whilst regretting its misrepresentation of the evidence on the latter, flawed interpretations of the relationship between human rights and drug control treaties, and a lack of constructive thinking on how to address the proliferation of systemic breaches in the global drug control regime.
IDPC, CDPE, Instituto RIA, HRI and the Health[e]Foundation provide data and recommendations on the importance of decriminalisation to fulfil the human rights of people who use drugs.
ICEERS estimates global lifetime ayahuasca use at above four million and notes that no media-reported deaths have been corroborated by forensic analysis.
UNAIDS underscores how increased political will is needed to end AIDS by investing in sustainable responses that include evidence-based prevention and treatment, health systems integration, non-discriminatory laws, gender equality and strong community networks.
The Canadian Drug Policy Coalition provides insight about value-based and implementation-focused priorities that centre drug user leadership in the development and expansion of safe supply models in Canada.
Olding et al. highlight the many functions that overdose prevention sites play in people's lives and how adaptations to high demand can have unintended impacts on these, underscoring the importance of complementary structural changes and service innovations.
IDPC calls on the UN system and Member States to initiate a process to evaluate the human rights impacts of the global drug control regime, and to propose concrete steps for its reform and modernisation.
The Scottish government proposes reforms to the UK's drug laws to support a public health approach that facilitates harm reduction measures, including decriminalisation and debate on regulated drug markets.
Van Selm et al. highlight the considerable lack of data regarding migrants who use drugs and their access to drug dependency services, with 15 recommendations designed to improve data collection and service accessibility and availability,
Scher et al. highlight, based on interviews with people who use drugs, how the criminalisation of drugs shapes experiences of structural, social and self stigma.
Rigoni et al. summarise expert and public opinions on the regulation of MDMA collected in relation to a pop-up installation (the 'XTC store') in Utrecht (the Netherlands) highlighting support for a strictly regulated market for MDMA products.
